Variable |
HR (CI 95) |
p-value |
Adjusted HR (CI 95) |
p-value |
Sex: Male vs Female (Ref) |
0.92 (0.73 – 1.16) |
0.479 |
0.92 (0.69 –
1.21) |
0.533 |
Age (10-year period increase) |
1.35 (1.15 – 1.36) |
<0.001 |
1.36 (1.22 – 1.50) |
<0.001 |
Group of pH |
|
<0.001 |
|
|
>7.2
|
Ref
|
|
|
|
7.0 – 7.2
|
1.39 (1.06 – 1.82)
|
0.016
|
1.42 (1.02 – 1.97)
|
0.038
|
<7.0
|
3.85 (2.83 – 5.23)
|
<0.001
|
5.07 (3.20 – 8.04)
|
<0.001
|
Implantation site |
|
|
|
|
Central
|
Ref
|
|
Ref
|
|
Peripheral
|
3.88 (0.48 – 1.17)
|
0.202
|
0.63 (0.35 – 1.12)
|
0.069
|
ECMO indication |
|
|
|
|
Refractory cardiac arrest
|
Ref
|
|
Ref
|
|
Refractory cardiogenic shock
|
0.55 (0.39 – 0.78)
|
0.001
|
1.36 (0.82 – 2.25)
|
0.229
|
Post-cardiotomy
|
0.72 (0.51 – 1.03)
|
0.069
|
1.18 (0.69 – 2.01)
|
0.554
|
Post-transplantation
|
0.40 (0.25 – 0.63)
|
<0.001
|
0.99 (0.53 – 1.85)
|
0.976
|
ECMO implantation under external CPR |
2.12 (1.68 – 2.70) |
<0.001 |
1.63 (1.13 – 2.35) |
0.009 |
Resuscitated cardiac arrest |
2.25 (1.29 – 3.92) |
0.005 |
|
|
Kidney (failure vs normal) |
2.05 (1.63 – 2.58) |
<0.001 |
1.56 (1.19 – 2.06) |
0.001 |
DBP ≥40 vs <40 |
0.56 (0.40 – 0.79) |
<0.001 |
0.56
(0.39 – 0.81) |
0.009 |
Bicarbonates (>15 vs ≤15) |
0.41 (0.20 – 0.83) |
0.013 |
|
|
Plateau pressure (>20 vs ≤20) |
1.08 (0.85 – 1.37) |
0.520 |
|
|
Lactates ≥7 vs < 7 |
1.84 (1.47 – 2.31) |
<0.001 |
|
|
Liver failure |
1.49 (1.15 – 1.92) |
0.002 |
|
|